![](/img/cover-not-exists.png)
932PDEfficacy of olaparib maintenance therapy in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSROC) by lines of prior chemotherapy: Phase III SOLO2 trial (ENGOT Ov-21)
Penson, R., Kaminsky-Forrett, M-C., Ledermann, J., Brown, C., Plante, M., Korach, J., Huzarski, T., Gomez de Liano Lista, A., Pisano, C., Friedlander, M., Colombo, N., Gropp-Meier, M., Nakai, H., SonkVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx372.002
Date:
September, 2017
File:
PDF, 92 KB
english, 2017